Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • COSMETICS—S.D.N.Y.: Amendment of acne product complaint leaves blemishes for dismissal in unapproved areas
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—D.D.C.: Physician’s claim against DEA challenging delay in agency action was moot
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—OIG REPORTS: MAOs paid $72M to revoked providers for services
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CIVIL MONEY PENALTIES—DAB DECISIONS: Inconsistent supervision supports immediate-jeopardy penalty for resident abuse
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • COST REPORTS—PRRB DECISIONS: PRRB rejects hospital’s appeal of unclaimed capital lease interest
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • EXPERT INSIGHTS—Janssen Granted Preliminary Injunction Against Golimumab Biosimilar
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FALSE CLAIMS ACT—D. N.J.: Court grants motion to dismiss in false claims action against pharmaceutical company
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • LABELING AND PACKAGING (FOOD, DRUGS & MEDICAL DEVICES)—S.D. Cal.: ‘Made with Real Fruit Juice’ not misleading where gummy snack product contained pear juice concentrate
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • MEDICAL DEVICES—FINAL RULES: Certain Class II clinical toxicology test systems exempted from premarket notification
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • MEDICAL DEVICES—FINAL RULES: Classification of the focused ultrasound system for non-thermal, mechanical tissue ablation
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • MEDICAL DEVICES—FINAL RULES: Classification of the high throughput DNA sequencing for hereditary cancer predisposition assessment test system
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PREEMPTION OF STATE LAW—3rd Cir.: Manufacturing defect and negligence claims against medical device manufacturer were not preempted by federal law
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, EXPERT INSIGHTS—Janssen Granted Preliminary Injunction Against Golimumab Biosimilar, (Oct 7, 2026)

    By Wendy Leben and Emma Murray of Goodwin Procter LLP

    On September 30, 2026, the U.S. District Court for the District of Delaware issued an order granting Janssen Biotech, Inc. and Janssen Sciences Ireland UC's (collectively, "Janssen") motion for a preliminary injunction in Janssen Biotech, Inc. v. Acc ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use